4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-036102
Chief Financial Officer sold 281 shares at $162.66 ($45,707)
- Chief Financial Officer acquired 8,935 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-19 | Grant or award : show line 1 in the form | +8,935 | 39,292 | D | ||
| 2021-05-24 | Sale : show line 2 in the form | −281 | $162.66 | $45,707 | 39,011 | D |
| Open-market sales · 281 sh · avg $162.66 · $45,707 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-19 | Grant or award : show line 3 in the form Stock Option (right to buy) | +22,338 | $177.76 | 2031-03-19 | 22,338 | 22,338 | D |
Loading xslF345X03/doc4.xml…